| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A multicenter evaluation of sweat chloride concentration and variation in infants with cystic fibrosis
|
LeGrys, V.A.
|
|
2019
|
18 |
2 |
p. 190-193
|
artikel
|
| 2 |
Antimicrobial susceptibility testing (AST) and associated clinical outcomes in individuals with cystic fibrosis: A systematic review
|
Somayaji, Ranjani
|
|
2019
|
18 |
2 |
p. 236-243
|
artikel
|
| 3 |
A specialized method of sputum collection and processing for therapeutic interventions in cystic fibrosis
|
McElvaney, O.J.
|
|
2019
|
18 |
2 |
p. 203-211
|
artikel
|
| 4 |
Associating antimicrobial susceptibility testing with clinical outcomes in cystic fibrosis: More rigor and less frequency?
|
Szczesniak, Rhonda D.
|
|
2019
|
18 |
2 |
p. 159-160
|
artikel
|
| 5 |
Biofabrication of personalised anatomical models and tools for the clinic
|
Allenby, Mark C.
|
|
2019
|
18 |
2 |
p. 161-162
|
artikel
|
| 6 |
Colocolonic intussusception in an adult cystic fibrosis patient
|
Timothy Adewale, Adegboyega
|
|
2019
|
18 |
2 |
p. e11-e13
|
artikel
|
| 7 |
Combined antifungal therapy is superior to monotherapy in pulmonary scedosporiosis in cystic fibrosis
|
Schwarz, Carsten
|
|
2019
|
18 |
2 |
p. 227-232
|
artikel
|
| 8 |
Comment on “repeated hot water and steam disinfection of pari LC Plus® nebulizers alter nebulizer output”
|
Millar, B. Cherie
|
|
2019
|
18 |
2 |
p. e16
|
artikel
|
| 9 |
Controlled attenuation parameter: A measure of hepatic steatosis in patients with cystic fibrosis
|
Bader, Razan M.
|
|
2019
|
18 |
2 |
p. 280-285
|
artikel
|
| 10 |
Correspondence between symptoms and preference-based health status measures in the STOP study
|
Gold, Laura S.
|
|
2019
|
18 |
2 |
p. 251-264
|
artikel
|
| 11 |
Cystic fibrosis related diabetes is not independently associated with increased Stenotrophomonas maltophilia infection: Longitudinal data from the UK CF Registry
|
Frost, Freddy
|
|
2019
|
18 |
2 |
p. 294-298
|
artikel
|
| 12 |
Cystic fibrosis: We see fungus among us, but should we care?
|
Hong, Gina
|
|
2019
|
18 |
2 |
p. 163-164
|
artikel
|
| 13 |
3D Printing and the Cystic Fibrosis Lung
|
Mirza, Alicia A.
|
|
2019
|
18 |
2 |
p. 278-279
|
artikel
|
| 14 |
Editorial Board
|
|
|
2019
|
18 |
2 |
p. ii
|
artikel
|
| 15 |
Electrochemical measurement of membrane cholesterol correlates with CFTR function and is HDAC6-dependent
|
Lu, Binyu
|
|
2019
|
18 |
2 |
p. 175-181
|
artikel
|
| 16 |
How reliable is your HbA1c test? Revisiting the use of HbA1c in cystic fibrosis-related diabetes (CFRD) screening
|
Lam, Grace Y.
|
|
2019
|
18 |
2 |
p. e14-e15
|
artikel
|
| 17 |
Human epididymis protein 4 (HE4) levels inversely correlate with lung function improvement (delta FEV1) in cystic fibrosis patients receiving ivacaftor treatment
|
Nagy Jr, Béla
|
|
2019
|
18 |
2 |
p. 271-277
|
artikel
|
| 18 |
IVACAFTOR restores FGF19 regulated bile acid homeostasis in cystic fibrosis patients with an S1251N or a G551D gating mutation
|
van de Peppel, Ivo P.
|
|
2019
|
18 |
2 |
p. 286-293
|
artikel
|
| 19 |
Mental Health screening in cystic fibrosis centres across Europe
|
Abbott, J.
|
|
2019
|
18 |
2 |
p. 299-303
|
artikel
|
| 20 |
News
|
|
|
2019
|
18 |
2 |
p. 165-166
|
artikel
|
| 21 |
Phenotypic spectrum of patients with cystic fibrosis and cystic fibrosis-related disease carrying p.Arg117His
|
Keenan, Katherine
|
|
2019
|
18 |
2 |
p. 265-270
|
artikel
|
| 22 |
Positive clinical response to ivacaftor treatment in an individual with the CFTR genotype F508del/V456A
|
Bratcher, Preston E.
|
|
2019
|
18 |
2 |
p. e9-e10
|
artikel
|
| 23 |
Prevalence and diversity of filamentous fungi in the airways of cystic fibrosis patients – A Dutch, multicentre study
|
Engel, Tobias G.P.
|
|
2019
|
18 |
2 |
p. 221-226
|
artikel
|
| 24 |
Prevalence, geographic risk factor, and development of a standardized protocol for fungal isolation in cystic fibrosis: Results from the international prospective study “MFIP”
|
Delhaes, Laurence
|
|
2019
|
18 |
2 |
p. 212-220
|
artikel
|
| 25 |
Repeated hot water and steam disinfection of Pari LC Plus® nebulizers alter nebulizer output
|
Collins, Melanie Sue
|
|
2019
|
18 |
2 |
p. 233-235
|
artikel
|
| 26 |
Repeated hot water and steam disinfection of pari LC Plus® nebulizers alters nebulizer output
|
Collins, Melanie Sue
|
|
2019
|
18 |
2 |
p. e17-e18
|
artikel
|
| 27 |
RNA sequencing data from neutrophils of patients with cystic fibrosis reveals potential for developing biomarkers for pulmonary exacerbations
|
Jiang, Kaiyu
|
|
2019
|
18 |
2 |
p. 194-202
|
artikel
|
| 28 |
R560S: A class II CFTR mutation that is not rescued by current modulators
|
Awatade, Nikhil T.
|
|
2019
|
18 |
2 |
p. 182-189
|
artikel
|
| 29 |
SPX-101 is stable in and retains function after exposure to cystic fibrosis sputum
|
Sesma, Juliana I.
|
|
2019
|
18 |
2 |
p. 244-250
|
artikel
|
| 30 |
The increasing challenge of genetic counseling for cystic fibrosis
|
Foil, Kimberly E.
|
|
2019
|
18 |
2 |
p. 167-174
|
artikel
|
Tijdschrift beschrijving